Cancer Clinical Trial Patients’ Perceptions of Reporting Adverse Events Via an Electronic Platform
To our knowledge, this is the first study that investigates, in-depth, the participant experience of self-reporting cancer clinical trial AE data via an electronic platform. Our study lends evidence from the participant-perspective to previously-reported studies investigating the feasibility of collecting AE data directly from the patient. Participants agreed that the platform was feasible and would be of benefit to future cancer clinical trial participants.
Authors
- Laurelie R. Wishart (ORCID: https://orcid.org/0000-0002-9474-9121)
- Bena Brown (ORCID: https://orcid.org/0000-0002-7537-2402)
- Minna Grahvendy (ORCID: https://orcid.org/0000-0001-9318-9778)
Institutions
- Griffith University (AU)
- The University of Queensland (AU)
- Royal Brisbane and Women's Hospital (AU)
- Princess Alexandra Hospital (AU)
- Metro South Health (AU)
Publication Details
- Journal
- Therapeutic Innovation & Regulatory Science
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1007/s43441-025-00804-z
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Queensland